Try our mobile app

Published: 2023-06-12 21:54:13 ET
<<<  go to RDY company page
EX-99.1 2 drr0485_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507  

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

June 12, 2023

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Limited (Scrip Code: 500124)

 

Dear Sirs,

 

Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

 

This is to inform you that the Company’s management will be participating in the following investor conference and group / institutional investor meetings:

 

Date Organized by Meeting details Location Timing
13-Jun-23 Goldman Sachs 44th Annual Global Healthcare Conference

California,

US

08:40 to 17:15 hrs PDT

(from 9:10 pm IST)

15-Jun-23 BofA Securities Investor group meeting Virtual 16:00 to 17:00 hrs IST
19-Jun-23 Kotak Securities Investor group meeting Hyderabad 10:00 to 11:00 hrs IST
14:00 to 17:00 hrs IST
20-Jun-23 JM Financial Institutional Securities Investor group meeting Hyderabad 10:00 to 11:30 hrs IST

 

Please note that the schedules of the aforesaid meetings are subject to change due to any exigencies on the part of Investors / Company.

 

This is for your information.

 

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

/s/ K Randhir Singh    
K Randhir Singh  

Company Secretary, Compliance Officer and Head CSR

 

CC:-New York Stock Exchange Inc.(Stock Code :RDY)

NSE IFSC Ltd